Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
Express Scripts
Colorcon
Baxter
Federal Trade Commission
Citi
US Department of Justice
US Army
Argus Health

Generated: April 20, 2018

DrugPatentWatch Database Preview

PLASMA-LYTE 56 AND DEXTROSE 5% IN PLASTIC CONTAINER Drug Profile

« Back to Dashboard

Which patents cover Plasma-lyte 56 And Dextrose 5% In Plastic Container, and what generic alternatives are available?

Plasma-lyte 56 And Dextrose 5% In Plastic Container is a drug marketed by Baxter Hlthcare and is included in one NDA.

The generic ingredient in PLASMA-LYTE 56 AND DEXTROSE 5% IN PLASTIC CONTAINER is dextrose; magnesium acetate tetrahydrate; potassium acetate; sodium chloride. There are eight drug master file entries for this compound. Additional details are available on the dextrose; magnesium acetate tetrahydrate; potassium acetate; sodium chloride profile page.
Summary for PLASMA-LYTE 56 AND DEXTROSE 5% IN PLASTIC CONTAINER
Drug patent expirations by year for PLASMA-LYTE 56 AND DEXTROSE 5% IN PLASTIC CONTAINER

US Patents and Regulatory Information for PLASMA-LYTE 56 AND DEXTROSE 5% IN PLASTIC CONTAINER

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Baxter Hlthcare PLASMA-LYTE 56 AND DEXTROSE 5% IN PLASTIC CONTAINER dextrose; magnesium acetate tetrahydrate; potassium acetate; sodium chloride INJECTABLE;INJECTION 017385-001 Approved Prior to Jan 1, 1982 RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
Accenture
Queensland Health
Chubb
Argus Health
Farmers Insurance
Healthtrust
Covington
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.